Citurgia Biochemicals Limited

Citurgia Biochemicals Limited

BBSE:CITURGIA
102.45
INR
-1.00
(-0.97%)
-0.06EPS
15.53BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.06
-0.06
-0.05
-0.04
-0.04
-0.21
-0.15
-0.23
-0.15
-0.17
-0.04
-0.03
-0.06
-0.06
Free Cash Flow per Basic Share
0.01
- -
-0.01
-0.04
-0.1
-0.07
-0.04
-0.06
-0.01
-0.03
-0.01
-0.01
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.09
-0.15
-0.2
-0.24
-0.28
-0.32
-0.35
-0.4
-0.43
-0.46
-0.5
-0.53
-0.59
- -
Tangible Book Value per Share
-0.09
-0.15
-0.2
-0.24
-0.28
-0.32
-0.35
-0.4
-0.43
-0.46
-0.5
-0.53
-0.59
- -
Basic Weighted Avg Shares
132
132
132
132
132
26
26
26
26
26
132
132
132
132
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
7
6
5
4
4
3
3
2
2
2
2
2
2
2
Net Income, GAAP
-8
-8
-7
-5
-6
-6
-4
-6
-4
-4
-5
-4
-7
-7
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
-12
-14
-16
-9
2
- -
-1
-3
-5
-7
-7
-8
-12
- -
LT Debt
44
45
45
51
64
64
64
65
65
65
67
68
69
- -
Total Equity
-12
-19
-26
-31
-37
-42
-46
-53
-57
-61
-66
-70
-77
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
69
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
132
132
132
Market Capitalization
- -
23,037
15,528

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
83
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
81
- -
Total Current Liabilities
- -
95
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.64%
8.05%
10.62%
Free Cash Flow
78.12%
32.15%
12.94%
Net Income, GAAP
5.82%
9.49%
75.49%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.01
-0.01
-0.01
-0.01
-0.03
2026
-0.01
-0.01
-0.02
-0.02
-0.06
2027
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Kashi Nath Jha
Sector
Process industries
Industry
Chemicals: specialty
Address
Mumbai India
IPO Date
Jan 1, 1990
Business
Citurgia Biochemicals Limited is an India-based biochemical and specialty chemical manufacturing enterprise. Founded in 1974 and headquartered in Mumbai, Maharashtra, the company historically engages in the manufacture, processing, and distribution of fermentation-based biochemicals and industrial chemical compounds. The company's core product offerings comprise Citric Acid, utilized as an acidulant, buffering agent, and preservative across the food, beverage, confectionery, and pharmaceutical sectors, as well as in industrial textile applications including acrylic print curing, cotton-resist printing, and pH stabilization during synthetic fiber processing; Precipitated Calcium Carbonate (PCC), utilized as a functional filler, extender, and whitening agent across paper, rubber, plastics, paints, and dentifrice formulations; and Plasticizers, designed to enhance the flexibility, durability, and workability of polymeric resins and industrial materials. The company historically established production operations in Rishikesh, Uttarakhand, and industrial ties in Gujarat, serving domestic and industrial markets across India. In recent corporate developments, Citurgia Biochemicals Limited has focused on corporate restructuring, governance realignment, and statutory compliance. Key recent milestones include the formal revocation of the trading suspension on its equity shares by the BSE in February 2026, executive management reorganizations including the appointment of a new Chief Financial Officer, Company Secretary, and reconstituted Board of Directors, and regulatory approvals from the Registrar of Companies (ROC), Mumbai, for extensions to convene its 51st Annual General Meeting and regularize periodic financial reporting.